These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10322566)

  • 1. [Is self-management practical in bronchial asthma?].
    Gonon M; Solèr M; Langewitz W; Perruchoud AP
    Schweiz Med Wochenschr; 1999 Apr; 129(13):519-25. PubMed ID: 10322566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A self-management program for adult asthma: part IV, Analysis of context and patient behaviors.
    Creer TL; Caplin DA; Holroyd KA
    J Asthma; 2005; 42(6):455-62. PubMed ID: 16293540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peak expiratory flow-guided self-management treatment of asthma in Serbia.
    Milenković BA; Stanković IJ; Ilić AM; Petrović VI
    J Asthma; 2007 Nov; 44(9):699-704. PubMed ID: 17994397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing asthma morbidity and mortality. Cost containment strategies.
    Kowalski AF
    AAOHN J; 2000 Sep; 48(9):418-22. PubMed ID: 11760288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term economic evaluation of intensive patient education during the first treatment year in newly diagnosed adult asthma.
    Kauppinen R; Vilkka V; Sintonen H; Klaukka T; Tukiainen H
    Respir Med; 2001 Jan; 95(1):56-63. PubMed ID: 11207019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peak-flow monitoring in asthmatic patients: indications and therapeutic implications of the measurements with reference to the 'traffic-light system'].
    Rothe TB
    Praxis (Bern 1994); 1996 Nov; 85(48):1542-9. PubMed ID: 8992566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cost-effectiveness analysis of a peak flow-based asthma education and self-management plan in a high-cost population.
    de Asis ML; Greene R
    J Asthma; 2004 Aug; 41(5):559-65. PubMed ID: 15360065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-management of asthma.
    Bramson R
    J Fam Pract; 1996 Jul; 43(1):21-2. PubMed ID: 8691172
    [No Abstract]   [Full Text] [Related]  

  • 10. A randomized, controlled study to evaluate the role of an in-home asthma disease management program provided by respiratory therapists in improving outcomes and reducing the cost of care.
    Shelledy DC; Legrand TS; Gardner DD; Peters JI
    J Asthma; 2009 Mar; 46(2):194-201. PubMed ID: 19253130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Education, self-management and home peak flow monitoring in childhood asthma.
    Kamps AW; Brand PL
    Paediatr Respir Rev; 2001 Jun; 2(2):165-9. PubMed ID: 12531064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring the patient with asthma: an evidence-based approach.
    Gibson PG
    J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):17-26. PubMed ID: 10887300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of inhaled fluticasone propionate and budesonide in the treatment of asthma in adults and children.
    Barnes NC; Thwaites RM; Price MJ
    Respir Med; 1999 Jun; 93(6):402-7. PubMed ID: 10464822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting response to therapy in acute asthma.
    Rodrigo GJ
    Curr Opin Pulm Med; 2009 Jan; 15(1):35-8. PubMed ID: 19077703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peak flow meter use in asthma management. Thoracic Society of Australia and New Zealand.
    Med J Aust; 1996 Jun; 164(12):727-30. PubMed ID: 8668080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of asthma--an analysis of clinical judgment among general practitioners].
    Lagerløv P; Fetveit A; Loeb M
    Tidsskr Nor Laegeforen; 2005 Nov; 125(21):2949-52. PubMed ID: 16276379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing and communicating a long-term treatment plan for asthma.
    Mellins RB; Evans D; Clark N; Zimmerman B; Wiesemann S
    Am Fam Physician; 2000 Apr; 61(8):2419-28, 2433-4. PubMed ID: 10794583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of personal best value of peak expiratory flow in patients with asthma--comparison of the highest value of daily PEF under good control and the highest value of daily PEF obtained after using repeated inhaled beta2-agonist during high-dose inhaled steroid treatment].
    Watanabe N; Makino S; Kihara N; Fukuda T
    Arerugi; 2008 Dec; 57(12):1284-92. PubMed ID: 19169083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M;
    Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of a structured outpatient education program for adult asthmatics].
    Schacher C; Dhein Y; Münks-Lederer C; Vollmer T; Worth H
    Dtsch Med Wochenschr; 2006 Mar; 131(12):606-10. PubMed ID: 16544235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.